| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966019 | Vaccine | 2013 | 8 Pages |
Abstract
Reducing the dose of serotype 4 antigen (5553 formulation) creates an imbalance in the immune response to CYD-TDV. Immune responses to CYD-TDV 5555 were slightly higher than to the 4444 formulation. Development of CYD-TDV 5555 has subsequently been pursued.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Gustavo H. Dayan, Manoj Thakur, Mark Boaz, Carol Johnson,